These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2986930)

  • 1. Buprenorphine.
    Lewis JW
    Drug Alcohol Depend; 1985 Feb; 14(3-4):363-72. PubMed ID: 2986930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral pharmacology of buprenorphine.
    Mello NK; Mendelson JH
    Drug Alcohol Depend; 1985 Feb; 14(3-4):283-303. PubMed ID: 3888577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse.
    Husbands SM; Lewis JW
    Mini Rev Med Chem; 2003 Mar; 3(2):137-44. PubMed ID: 12570846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.
    Negus SS; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 1990; 102(4):465-73. PubMed ID: 1965748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of self-administration.
    Balster RL; Lukas SE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):249-61. PubMed ID: 3888576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Feb; 17(2):81-110. PubMed ID: 378645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinforcing properties of buprenorphine: a behavioral analysis.
    Mello NK; Bree MP; Mendelson JH
    NIDA Res Monogr; 1981 Feb; 34():36-42. PubMed ID: 6783946
    [No Abstract]   [Full Text] [Related]  

  • 10. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.
    Jasinski DR; Pevnick JS; Griffith JD
    Arch Gen Psychiatry; 1978 Apr; 35(4):501-16. PubMed ID: 215096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of buprenorphine and methadone on opiate self-administration in primates.
    Mello NK; Bree MP; Mendelson JH
    NIDA Res Monogr; 1982 Apr; 41():67-73. PubMed ID: 6181414
    [No Abstract]   [Full Text] [Related]  

  • 12. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys.
    Kishioka S; Paronis CA; Lewis JW; Woods JH
    Eur J Pharmacol; 2000 Mar; 391(3):289-97. PubMed ID: 10729371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat.
    Tejwani GA; Rattan AK
    Anesth Analg; 2002 Jun; 94(6):1542-6, table of contents. PubMed ID: 12032023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations.
    Kajiwara M; Aoki K; Ishii K; Numata H; Matsumiya T; Oka T
    Jpn J Pharmacol; 1986 Jan; 40(1):95-101. PubMed ID: 3007830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa antagonist effects of buprenorphine in the rat drug-discrimination procedure.
    Negus SS; Picker MJ; Dykstra LA
    NIDA Res Monogr; 1989; 95():518-9. PubMed ID: 2561845
    [No Abstract]   [Full Text] [Related]  

  • 18. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.
    Bidlack JM
    Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphrine: demonstration of physical dependence liability.
    Dum J; Bläsig J; Herz A
    Eur J Pharmacol; 1981 Mar; 70(3):293-300. PubMed ID: 6262095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions.
    Dum JE; Herz A
    Br J Pharmacol; 1981 Nov; 74(3):627-33. PubMed ID: 6271322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.